| Literature DB >> 12563156 |
Naoto Hayashi1, Tomohiko Masumoto, Toshiyuki Okubo, Osamu Abe, Nobuyuki Kaji, Kazuyuki Tokioka, Shigeki Aoki, Kuni Ohtomo.
Abstract
The feasibility of a method of magnetic resonance (MR)-guided sclerotherapy for hemangioma was evaluated. The distribution of a test injection and a contiguous sclerosant injection was monitored clearly with MR fluoroscopy. Postsclerotherapy T2-weighted MR images depicted areas with and those without effective sclerosant concentration, which enabled performance of selective supplemental sclerotherapy. This method of MR-guided sclerotherapy seems feasible for clinical application.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12563156 DOI: 10.1148/radiol.2262012157
Source DB: PubMed Journal: Radiology ISSN: 0033-8419 Impact factor: 11.105